Evidence map›Paper›PMID 40753537›Full record

ReviewBriefings in bioinformatics2025

Approaching the holistic transcriptome-convolution and deconvolution in transcriptomics.

Maik Wolfram-Schauerte, Thomas Vogel, Hanati Tuoken, Maria Fälth Savitski, Eric Simon, Kay Nieselt

Abstract readReview
In one paragraph

Review in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Integration of Bulk and Single-Cell RNA Sequencing Analyses in Biomedicine.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maik Wolfram-SchauerteFaculty of Science, Department of Computer Science, Eberhard-Karls University Tübingen, Sand 14, D-72076 Tübingen, Baden-Württemberg, Germany.ORCID 0000-0001-6988-2775
Thomas VogelFaculty of Science, Department of Computer Science, Eberhard-Karls University Tübingen, Sand 14, D-72076 Tübingen, Baden-Württemberg, Germany.ORCID 0009-0008-5076-4785
Hanati TuokenComputational Innovation, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, D-88397 Biberach, Baden-Württemberg, Germany.
Maria Fälth SavitskiComputational Innovation, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, D-88397 Biberach, Baden-Württemberg, Germany.
Eric SimonComputational Innovation, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, D-88397 Biberach, Baden-Württemberg, Germany.ORCID 0000-0002-2585-3830
Kay NieseltFaculty of Science, Department of Computer Science, Eberhard-Karls University Tübingen, Sand 14, D-72076 Tübingen, Baden-Württemberg, Germany.ORCID 0000-0002-1283-7065

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tissues, organs, and entire organisms are composed of diverse cell populations, which are characterized by cell-type-specific gene activities. Bulk RNA-seq represents a robust, cost-effective, scalable method to measure gene activity at the bulk tissue level. However, pathomolecular processes lead to divergent changes in tissue composition and cell-type-specific gene deregulations, which cannot be resolved at the tissue bulk level without information on either change in cell-type proportion or expression at the single-cell level. Accordingly, methods have been developed that constrain bulk deconvolution by information from single-cell expression or cell-type proportion. In parallel, convolution methods have been developed to project single-cell expression to bulk tissue level (pseudobulk simulation). In the present review, we provide an overview of existing convolution and deconvolution methods, their interconnectivity, and benchmarking. Our unique approach lies in the joint consideration of both directions in a "holistic transcriptome model." Through analysis of published (de)convolution studies and benchmarks, we identified the reduced availability of suitable datasets and the use of inaccurate convolution-like methods for (de)convolution model assessment and training as key bottlenecks in the field. On that basis, we conclude with a holistic transcriptome model envisioning that a more integral approach to convolution and deconvolution is needed. With our suggestions for a unified framework we aim to spark collaborative efforts to enable major leaps forward in the field of (de)convolution.

Indexed as

Computational BiologyGene Expression ProfilingTranscriptomeAnimalsHumansSingle-Cell Analysisbulk RNA-Seqcell-type proportionsconvolutiondeconvolutionholistic transcriptomemachine learningscRNA-seqtranscriptomics

Identifiers

PMID40753537
PMCPMC12318476

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.